Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cardiovascular Prevention
100%
Low-density Lipoprotein Cholesterol (LDL-C)
100%
Cholesterol-lowering
100%
Low-for-long
100%
Atherosclerotic Cardiovascular Disease Risk
44%
Lifestyle Modification
22%
Primary Prevention
22%
Homozygous Familial Hypercholesterolemia (HoFH)
22%
Secondary Prevention
22%
Risk Factors
11%
Statins
11%
Ezetimibe
11%
Safety Concerns
11%
Coronary Artery Calcium
11%
Cumulative Exposure
11%
Lipids
11%
Novel Agents
11%
Armamentarium
11%
Therapeutic Monoclonal Antibody
11%
Statin Therapy
11%
Ultracentrifugation
11%
Risk Assessment
11%
Low-density Lipoprotein Cholesterol Level
11%
Lipid-lowering Therapy
11%
Prior Myocardial Infarction
11%
Primary Hypercholesterolemia
11%
Routine Clinical Practice
11%
Manuscript Review
11%
Lp(a)
11%
Accurate Calculation
11%
Intensive Lipid-lowering Therapy
11%
Therapy Modification
11%
RNA Therapy
11%
High-intensity Statin Therapy
11%
Treatment Landscape
11%
LDL Receptor
11%
Emerging Agents
11%
Risk Decision
11%
Bempedoic Acid
11%
Evinacumab
11%
PCSK9 Monoclonal Antibodies
11%
Patients with Diabetes
11%
Risk-enhancing Factors
11%
Non-statin Therapy
11%
Modification Approach
11%
Martin/Hopkins Equation
11%
Risk Frames
11%
Medicine and Dentistry
Cardiovascular Disease Prevention
100%
Low Density Lipoprotein Cholesterol
100%
Arteriosclerotic Heart Disease
100%
Statin
40%
Lipid
30%
Lifestyle Modification
20%
Decision Making
20%
Primary Prevention
20%
Familial Hypercholesterolemia
20%
Secondary Prevention
20%
Apoplexy
10%
Myocardial Infarction
10%
Patient with Diabetes
10%
Monoclonal Antibody
10%
Small Interfering RNA
10%
Cholesterol Ester Transfer Protein
10%
Hypercholesterolemia
10%
LDL Receptor
10%
Ezetimibe
10%
Bempedoic Acid
10%
Evinacumab
10%
Coronary Artery Calcium
10%
Oral
10%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Atherosclerosis
100%
Low Density Lipoprotein Cholesterol
100%
Statin (Protein)
30%
Lipid
30%
Familial Hypercholesterolemia
20%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
10%
Ezetimibe
10%
Heart Infarction
10%
Monoclonal Antibody
10%
Small Interfering RNA
10%
Hypercholesterolemia
10%
Cholesterol Ester Transfer Protein
10%
Low Density Lipoprotein Receptor
10%
Cerebrovascular Accident
10%
Bempedoic Acid
10%
Evinacumab
10%
Nursing and Health Professions
Low Density Lipoprotein Receptor
11%
Evinacumab
11%